Domestic biosimilar market will exceed USD 100 million by 2019
The domestic biosimilar market is expected to exceed USD 100 million by 2019.
The Biotech Policy Research Center expected the Korea biosimilar market will grow in the 7.8% CAGR from USD 70 million in 2012 to USD 120 million, according to its recent ‘BioINwatch(BioIN+Issue+Watch), 15-102’ report....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
